OnKure Therapeutics, Inc.

Onkure Therapeutics, Inc.

Biotechnology • Healthcare • Boulder, CO, United States • OKUR (NGM)

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.

720 307 2892 6707 Winchester Circle, Boulder, CO 80301, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

OnKure Therapeutics CFO Leverone sells $896 in stock - Investing.com
Investing.com • Dec 24
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update - GlobeNewswire
GlobeNewswire • Nov 6
Companies Like OnKure Therapeutics (NASDAQ:OKUR) Could Be Quite Risky - Yahoo Finance
Yahoo Finance • Aug 19
Onkure Therapeutics patents PI3K inhibitors - BioWorld MedTech
BioWorld MedTech • Oct 21
OnKure Therapeutics CEO Saccomano sells $258 in stock By Investing.com - Investing.com South Africa
Investing.com South Africa • Dec 24

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has OnKure Therapeutics, Inc. had layoffs?
No layoff events have been recorded for OnKure Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does OnKure Therapeutics, Inc. have?
OnKure Therapeutics, Inc. has approximately 46 employees.
What industry is OnKure Therapeutics, Inc. in?
OnKure Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is OnKure Therapeutics, Inc. a publicly traded company?
Yes, OnKure Therapeutics, Inc. is publicly traded under the ticker symbol OKUR on the NGM. The company has a market capitalization of approximately $0.04 billion.
Where is OnKure Therapeutics, Inc. headquartered?
OnKure Therapeutics, Inc. is headquartered in Boulder, CO, United States at 6707 Winchester Circle, Boulder, CO 80301, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.